Abstract A027: First-in-class oral macrocyclic Cyclin D1-selective inhibitors demonstrate anti-tumor activity in Cyclin D1-dependent tumors
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Nathan Gushwa, Bernard Levin, Nik Mendoza, Roberta Sala, Andrew Bockus, Justin Shapiro, Meisam Nosrati, Jinshu Fang, Benedict Tsai, Daphne He, Ming-Hsun Ho, Li-Fen Liu, Stefan Gerhardy, Anuja Modi, Kai Yang, Jacqueline Bustamante, Gabriel Fung, Breena Walton, Nathan Dupper, Miguel Baldomero, Joshua Luna, Chinmay Bhatt, Eric Weber, Catherine E. Gleason, Sammy Metobo, James Aggen, Peadar Cremin, Pablo D. Garcia, Matthew Jacobson, Constantine Kreatsoulas, David J. Earp, Marie Evangelista
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415444482
Cites:
Cited by:
Related to: